DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

ACUTAAS vs MANIPALHOS: Stock Comparison

ACUTAAS CHEMICALS vs MANIPAL HEALTH ENTERPRI LUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

MANIPAL HEALTH ENTERPRI L is the larger company by market capitalisation. ACUTAAS CHEMICALS shows a higher dividend yield, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ACUTAAS leads 7; MANIPALHOS leads 0 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ACUTAASMANIPALHOS

Valuation lens

What price are you paying?

Market CapContext only
₹30,997 Cr
₹85,013 Cr
P/E RatioSame reading
70.58x
—
P/B RatioSame reading
16.69x
—
EPSACUTAAS has the higher reading
₹15.29 ✓
₹1.76
Book ValueContext only
₹208.96
—
Dividend YieldACUTAAS has the higher reading
0.07% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
MANIPALHOS is the larger company
₹85,013 Cr vs ₹30,997 Cr
EPS
ACUTAAS has higher earnings per share
₹15.29 vs ₹1.76
Dividend Yield
ACUTAAS has a higher dividend yield
0.07% vs 0%
Revenue Growth (TTM YoY)
ACUTAAS has faster revenue growth
40.3% vs 0%
EPS Growth (TTM YoY)
ACUTAAS has faster EPS growth
105.6% vs 0%
Qtr Sales Growth
ACUTAAS has stronger quarterly sales growth
32.53% vs 0%
Qtr Profit Growth
ACUTAAS has stronger quarterly profit growth
64.21% vs 0%
Net Margin
ACUTAAS has a higher net margin
26.6% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricACUTAASMANIPALHOS
SectorHealthcare—
IndustryPharmaceuticals—

Price

MetricACUTAASMANIPALHOS
Live Price₹3,786.6₹646.7
Day Change0.42%-1.61%
Volume2.74 L3.55 L
52-Week High₹4,045.3₹815
52-Week Low₹1,570₹597
Distance from 52W High-6.4%-20.65%

Valuation

MetricACUTAASMANIPALHOS
Market Cap₹30,997 Cr₹85,013 Cr
P/E Ratio70.58x—
P/B Ratio16.69x—
EPS₹15.29₹1.76
Book Value₹208.96—
Dividend Yield0.07%0%

Growth

MetricACUTAASMANIPALHOS
Revenue Growth (TTM YoY)40.3%0%
EPS Growth (TTM YoY)105.6%0%
Qtr Sales Growth32.53%0%
Qtr Profit Growth64.21%0%

Profitability & Leverage

MetricACUTAASMANIPALHOS
ROE21.95%—
ROCE23.86%—
Net Margin26.6%0%
Operating Margin37.46%—
Debt to Equity0.01x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricACUTAASMANIPALHOS
Promoter Holding32.66%6.28%
FII Holding22.62%▲ 1.01 pp3.5%▼ 0.15 pp
DII Holding19.4%▼ 0.16 pp7.18%▲ 1.72 pp
Public Holding25.31%▼ 0.85 pp17.23%▼ 1.58 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ACUTAAS CHEMICALS and MANIPAL HEALTH ENTERPRI L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.